These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 15625124

  • 1. Comparison of CD34 and monocyte-derived dendritic cells from mobilized peripheral blood from cancer patients.
    Syme R, Bajwa R, Robertson L, Stewart D, Glück S.
    Stem Cells; 2005; 23(1):74-81. PubMed ID: 15625124
    [Abstract] [Full Text] [Related]

  • 2. Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
    Choi D, Perrin M, Hoffmann S, Chang AE, Ratanatharathorn V, Uberti J, McDonagh KT, Mulé JJ.
    Clin Cancer Res; 1998 Nov; 4(11):2709-16. PubMed ID: 9829733
    [Abstract] [Full Text] [Related]

  • 3. Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli.
    Chen B, Stiff P, Sloan G, Kash J, Manjunath R, Pathasarathy M, Oldenburg D, Foreman KE, Nickoloff BJ.
    Clin Immunol; 2001 Feb; 98(2):280-92. PubMed ID: 11161986
    [Abstract] [Full Text] [Related]

  • 4. Generation of dendritic cells from fresh and frozen cord blood CD34+ cells.
    Sato K, Nagayama H, Takahashi TA.
    Cryobiology; 1998 Dec; 37(4):362-71. PubMed ID: 9917353
    [Abstract] [Full Text] [Related]

  • 5. Dendritic cells generated either from CD34+ progenitor cells or from monocytes differ in their ability to activate antigen-specific CD8+ T cells.
    Ferlazzo G, Wesa A, Wei WZ, Galy A.
    J Immunol; 1999 Oct 01; 163(7):3597-604. PubMed ID: 10490952
    [Abstract] [Full Text] [Related]

  • 6. Autologous dendritic cells derived from CD34+ progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of melan-A/Mart-1(27-35)-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursors.
    Mortarini R, Anichini A, Di Nicola M, Siena S, Bregni M, Belli F, Molla A, Gianni AM, Parmiani G.
    Cancer Res; 1997 Dec 15; 57(24):5534-41. PubMed ID: 9407964
    [Abstract] [Full Text] [Related]

  • 7. Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile.
    Gelderblom HC, Nijhuis LE, de Jong EC, te Velde AA, Pajkrt D, Reesink HW, Beld MG, van Deventer SJ, Jansen PL.
    Liver Int; 2007 Sep 15; 27(7):944-53. PubMed ID: 17696933
    [Abstract] [Full Text] [Related]

  • 8. Dendritic cell subsets generated from CD34+ hematopoietic progenitors can be transfected with mRNA and induce antigen-specific cytotoxic T cell responses.
    Ueno H, Tcherepanova I, Reygrobellet O, Laughner E, Ventura C, Palucka AK, Banchereau J.
    J Immunol Methods; 2004 Feb 15; 285(2):171-80. PubMed ID: 14980432
    [Abstract] [Full Text] [Related]

  • 9. Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.
    Harada S, Kimura T, Fujiki H, Nakagawa H, Ueda Y, Itoh T, Yamagishi H, Sonoda Y.
    Int J Oncol; 2007 Jun 15; 30(6):1461-8. PubMed ID: 17487367
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dendritic cells can be successfully generated from CD34+ cord blood cells in the presence of autologous cord blood plasma.
    Borràs FE, Matthews NC, Patel R, Navarrete C.
    Bone Marrow Transplant; 2000 Aug 15; 26(4):371-6. PubMed ID: 10982282
    [Abstract] [Full Text] [Related]

  • 13. The functional immaturity of dendritic cells can be relevant to increased tolerance associated with cord blood transplantation.
    Encabo A, Solves P, Carbonell-Uberos F, Miñana MD.
    Transfusion; 2007 Feb 15; 47(2):272-9. PubMed ID: 17302774
    [Abstract] [Full Text] [Related]

  • 14. Tumor-associated macrophages as a source of functional dendritic cells in ovarian cancer patients.
    Chu CS, Woo EY, Toll AJ, Rubin SC, June CH, Carroll RG, Schlienger K.
    Clin Immunol; 2002 Mar 15; 102(3):291-301. PubMed ID: 11890716
    [Abstract] [Full Text] [Related]

  • 15. Phenotypic alterations and IL-1beta production in CD34(+) progenitor- and monocyte-derived dendritic cells after exposure to allergens: a comparative analysis.
    De Smedt AC, Van Den Heuvel RL, Van Tendeloo VF, Berneman ZN, Schoeters GE, Weber E, Tuschl H.
    Arch Dermatol Res; 2002 May 15; 294(3):109-16. PubMed ID: 12029496
    [Abstract] [Full Text] [Related]

  • 16. A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
    Ju S, Ju S, Ge Y, Qiu H, Lu B, Qiu Y, Fu J, Liu G, Wang Q, Hu Y, Shu Y, Zhang X.
    Int Immunol; 2009 Oct 15; 21(10):1135-44. PubMed ID: 19684160
    [Abstract] [Full Text] [Related]

  • 17. Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells.
    Bohnenkamp HR, Burchell JM, Taylor-Papadimitriou J, Noll T.
    J Immunol Methods; 2004 Nov 15; 294(1-2):67-80. PubMed ID: 15604017
    [Abstract] [Full Text] [Related]

  • 18. Efficient induction of specific cytotoxic T lymphocytes to tumor rejection peptide using functional matured 2 day-cultured dendritic cells derived from human monocytes.
    Tanaka F, Yamaguchi H, Haraguchi N, Mashino K, Ohta M, Inoue H, Mori M.
    Int J Oncol; 2006 Nov 15; 29(5):1263-8. PubMed ID: 17016660
    [Abstract] [Full Text] [Related]

  • 19. An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes.
    Milano F, van Baal JW, Rygiel AM, Bergman JJ, Van Deventer SJ, Kapsenberg ML, Peppelenbosch MP, Krishnadath KK.
    J Immunol Methods; 2007 Apr 10; 321(1-2):94-106. PubMed ID: 17336322
    [Abstract] [Full Text] [Related]

  • 20. Induction of leukemic-cell-specific cytotoxic T lymphocytes by autologous monocyte-derived dendritic cells presenting leukemic cell antigens.
    Lee JJ, Park MS, Park JS, Kang HK, Kim SK, Nguyen Pham TN, Zhu XW, Cho D, Nam JH, Kim YJ, Rhee JH, Chung IJ, Kim HJ.
    J Clin Apher; 2006 Oct 10; 21(3):188-94. PubMed ID: 16570260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.